RTC
MRTX

Riverview Trust Company’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Riverview Trust Company’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-347
Closed -$12.9K – 769
2023
Q1 		$12.9K Hold
347
– – 0.01% 606
2022
Q4 		$16K Hold
347
– – 0.02% 409
2022
Q3 		$24K Hold
347
– – 0.02% 333
2022
Q2 		$23K Buy
+347
New +$23K 0.02% 359